玮俊生物科技预计中期净亏损不超600万港元

Core Viewpoint - The company, Wei Jun Biotechnology (00660), anticipates a significant reduction in net loss for the six months ending December 31, 2025, with expected losses not exceeding HKD 6 million, compared to a net loss of approximately HKD 13.1 million for the six months ending December 31, 2024 [1] Group 1 - The expected net loss for the upcoming reporting period is projected to be less than HKD 6 million [1] - This represents a substantial decrease from the previous period's net loss of about HKD 13.1 million [1] - The primary reasons for the reduced loss are an increase in revenue and a decrease in financial costs during the reporting period [1]